Vanguard Global Advisers
TIL icon

Vanguard Global Advisers’s Instil Bio TIL Stock Holding History

Vanguard Global Advisers’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Hold
1,470
– – ﹤0.01% 3459
2026
Q1 		$12.1K Buy
+1,470
New +$11.9K ﹤0.01% 3447

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Global Advisers's TIL Position: Q2 2026 in Review

Vanguard Global Advisers held its Instil Bio (TIL) position steady in Q2 2026 at 1,470 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3459.

Vanguard Global Advisers first reported a position in TIL in Q1 2026 and has held it in 2 quarters since. The position peaked at $12.1K in Q1 2026. 24 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Vanguard Global Advisers held 1,470 shares of Instil Bio worth $11.3K as of Q2 2026.
  • Vanguard Global Advisers left its Instil Bio share count unchanged in Q2 2026.
  • Instil Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3459 holding.
  • Vanguard Global Advisers first reported a position in Instil Bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Instil Bio position peaked at $12.1K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.